Mohamed Ayed

Background

About Mohamed Ayed

With over 12 years of experience in the pharmaceutical industry, I’ve developed a strong track record in sales excellence, portfolio management, and cross-functional collaboration across diverse therapeutic areas. From 2013 to 2022 at Novartis, I held roles as a Cardiovascular Medical Sales Representative, managing the Valsartan portfolio and delivering exceptional performance year over year. I later advanced to the role of National Key Account Manager, overseeing the total Novartis portfolio and driving access initiatives on a national scale. In 2023, I joined Sandoz as a Cardio Product Specialist, contributing to the successful launch of SPC cardiovascular therapies. In this role, I successfully delivered significant breakthrough results within a short time and contributed to strategic positioning initiatives focused on enhancing patient outcomes and quality of life. Currently, in 2025, I am continuing the same project under IQVIA (CSO for Sandoz), after previously working directly with Sandoz. I am responsible for promoting the Branded generics portfolio in Cardiovascular and Pain. I manage territory development, drive sales growth, and strengthen territorial advocacy through effective stakeholder engagement. I am highly adaptable to different environments and cultures and am eager to leverage my experience and skills to explore new opportunities. I am passionate about personal and professional growth, continually seeking to enhance my profile and contribute to business progress wherever possible.